Topics

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

04:13 EST 15 Jan 2020 | NEJM

Original Article: Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

NEXT ARTICLE

More From BioPortfolio on "Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients"

Quick Search